Servier today announced longer-term data from the Phase 3 INDIGO trial evaluating VORANIGO® (vorasidenib) versus placebo in patients with Grade 2 mutant isocitrate dehydrogenase 1 or 2 (mIDH1/2) ...
Canterra Minerals Corp. is pleased to announce that drilling of new high-grade gold targets on the Company's Wilding Gold Project has commenced. New geological understanding developed from both the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback